• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
535469
INE0LA901015
13.9005528
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JFLLIFE
4.88
33
EPS(TTM)
Face Value()
Div & Yield %
2.05
10
0
 

Ideaforge Tech gains after board OKs opening of QIP
Jul 08,2026
The company authorized the opening of issue on 7 July 2026.

The floor price of Rs 835.86 per equity share is at a discount 0.26% to the scrip's previous closing price of Rs 838 recorded on the BSE on Tuesday (7 July 2026).

Ideaforge Technology is a market leader in the Indian unmanned aircraft systems (UAS) market. It ranked 3rd globally in the dual-use category (civil and defense) drone manufacturers as per the report published by Drone Industry Insights in December 2024.

On a consolidated basis, the company reported net profit of Rs 59.99 crore in Q4 March 2026 as against net loss of Rs 25.71 crore in Q4 March 2025. Net sales soared 594.44% YoY to Rs 141.04 crore in Q4 March 2026.